The DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index.
Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Developments of a water-maze procedure for studying spatial learning in the rat
Morris, R. (1984) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(84)90007-4 · Cited by 7,180
Bioavailability of curcumin: Problems and promises
Anand, P., Kunnumakkara, A. B., Newman, R. A., & Aggarwal, B. B. (2007) · Molecular Pharmaceutics · doi:10.1021/mp700113r · Cited by 5,543
Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
Self-citationIn Vivo Imaging of Quantum Dots Encapsulated in Phospholipid Micelles
Dubertret, B., Skourides, P., Norris, D. J., Noireaux, V., Brivanlou, A. H., & Libchaber, A. (2002) · Science · doi:10.1126/science.1077194 · Cited by 3,019
Nanomedicine: current status and future prospects
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2005) · The FASEB Journal · doi:10.1096/fj.04-2747rev · Cited by 2,029
Self-citationImmunological properties of engineered nanomaterials
Dobrovolskaia, M. A., & McNeil, S. E. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.223 · Cited by 1,823
Rapid induction of Alzheimer A beta amyloid formation by zinc
Bush, A., Pettingell, W., Multhaup, G., d Paradis, M., Vonsattel, J., Gusella, J., Beyreuther, K., Masters, C., & Tanzi, R. (1994) · Science · doi:10.1126/science.8073293 · Cited by 1,522
Solid lipid nanoparticles for parenteral drug delivery
Wissing, S. A., Kayser, O., & Müller, R. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.12.002 · Cited by 1,495
Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability
Dahlgren, K. N., Manelli, A. M., Stine, W. B., Baker, L. K., Krafft, G. A., & LaDu, M. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201750200 · Cited by 1,452
Acetylcholinesterase — new roles for an old actor
Soreq, H., & Seidman, S. (2001) · Nature Reviews Neuroscience · doi:10.1038/35067589 · Cited by 1,390
Iron accumulation in Alzheimer disease is a source of redox-generated free radicals
Smith, M. A., Harris, P. L. R., Sayre, L. M., & Perry, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9866 · Cited by 1,355
Nanogels as Pharmaceutical Carriers: Finite Networks of Infinite Capabilities
Kabanov, A. V., & Vinogradov, S. V. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200900441 · Cited by 1,313
CSF markers for incipient Alzheimer's disease
Blennow, K., & Hampel, H. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00530-1 · Cited by 1,291
Nanoparticulate systems for brain delivery of drugs.
Kreuter, J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00122-8 · Cited by 1,107
Masella, R., Di Benedetto, R., Varì, R., Filesi, C., & Giovannini, C. (2005) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2005.05.013 · Cited by 1,107
A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy
Moghimi, S. M., Symonds, P., Murray, J. C., Hunter, A. C., Debska, G., & Szewczyk, A. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.02.010 · Cited by 1,092
Self-citationArrest of -Amyloid Fibril Formation by a Pentapeptide Ligand
Tjernberg, L. O., Näslund, J., Lindqvist, F., Johansson, J., Karlström, A. R., Thyberg, J., Terenius, L., & Nordstedt, C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.15.8545 · Cited by 963
Nanoparticulate systems for brain delivery of drugs
Kreuter, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.015 · Cited by 958
Krusic, P. J., Wasserman, E., Keizer, P. N., Morton, J. R., & Preston, K. F. (1991) · Science · doi:10.1126/science.254.5035.1183 · Cited by 925
Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides
Chen, J., Patil, S., Seal, S., & McGinnis, J. F. (2006) · Nature Nanotechnology · doi:10.1038/nnano.2006.91 · Cited by 880
Haes, A. J., Chang, L., Klein, W. L., & Van Duyne, R. P. (2005) · Journal of the American Chemical Society · doi:10.1021/ja044087q · Cited by 864
Georganopoulou, D. G., Chang, L., Nam, J.-M., Thaxton, C. S., Mufson, E. J., Klein, W. L., & Mirkin, C. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409336102 · Cited by 835
de Vries, I. J. M., Lesterhuis, W. J., Barentsz, J. O., Verdijk, P., van Krieken, J. H., Boerman, O. C., Oyen, W. J. G., Bonenkamp, J. J., Boezeman, J. B., Adema, G. J., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1154 · Cited by 821
Structure–neurotoxicity relationships of amyloid β-protein oligomers
Ono, K., Condron, M. M., & Teplow, D. B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905127106 · Cited by 770
Intramuscular desferrioxamine in patients with Alzheimer's disease
MCLACHLAN, D. (1991) · The Lancet · doi:10.1016/0140-6736(91)92978-b · Cited by 764
Zinc in the physiology and pathology of the CNS
Sensi, S. L., Paoletti, P., Bush, A. I., & Sekler, I. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2734 · Cited by 759
Carboxyfullerenes as neuroprotective agents
Dugan, L. L., Turetsky, D. M., Du, C., Lobner, D., Wheeler, M., Almli, C. R., Shen, C. K.-F., Luh, T.-Y., Choi, D. W., & Lin, T.-S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9434 · Cited by 748
A Localized Surface Plasmon Resonance Biosensor: First Steps toward an Assay for Alzheimer's Disease
Haes, A. J., Hall, W. P., Chang, L., Klein, W. L., & Van Duyne, R. P. (2004) · Nano Letters · doi:10.1021/nl049670j · Cited by 710
Stiriba, S.-E., Frey, H., & Haag, R. (2002) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20020415)41:8<1329::aid-anie1329>3.0.co;2-p · Cited by 672
Atwood, C. S., Scarpa, R. C., Huang, X., Moir, R. D., Jones, W. D., Fairlie, D. P., Tanzi, R. E., & Bush, A. I. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751219.x · Cited by 641
Amyloid β-Protein Assembly and Alzheimer Disease
Roychaudhuri, R., Yang, M., Hoshi, M. M., & Teplow, D. B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r800036200 · Cited by 615
Arispe, N., Pollard, H. B., & Rojas, E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10573 · Cited by 557
Mittal, G., Sahana, D. K., Bhardwaj, V., & Ravi Kumar, M. N. V. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.01.016 · Cited by 551
100 Years and Counting: Prospects for Defeating Alzheimer's Disease
Roberson, E. D., & Mucke, L. (2006) · Science · doi:10.1126/science.1132813 · Cited by 550
Inhibition of Amyloid β Protein Fibrillation by Polymeric Nanoparticles
Cabaleiro-Lago, C., Quinlan-Pluck, F., Lynch, I., Lindman, S., Minogue, A. M., Thulin, E., Walsh, D. M., Dawson, K. A., & Linse, S. (2008) · Journal of the American Chemical Society · doi:10.1021/ja8041806 · Cited by 546
Sayre, L. M., Perry, G., Harris, P. L. R., Liu, Y., Schubert, K. A., & Smith, M. A. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0740270.x · Cited by 540
Protective actions of sex steroid hormones in Alzheimer’s disease
Pike, C. J., Carroll, J. C., Rosario, E. R., & Barron, A. M. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.04.015 · Cited by 522
A Potential Role of the Curry Spice Curcumin in Alzheimers Disease
Ringman, J., Frautschy, S., Cole, G., Masterman, D., & Cummings, J. (2005) · Current Alzheimer Research · doi:10.2174/1567205053585882 · Cited by 518
Localized Surface Plasmon Resonance Biosensors
Zhao, J., Zhang, X., Yonzon, C. R., Haes, A. J., & Van Duyne, R. P. (2006) · Nanomedicine · doi:10.2217/17435889.1.2.219 · Cited by 508
PHARMACOKINETICS AND PHARMACODYNAMICS OF CURCUMIN
Sharma, R. A., Steward, W. P., & Gescher, A. J. (2007) · ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY · doi:10.1007/978-0-387-46401-5_20 · Cited by 476
Nonviral delivery of synthetic siRNAs in vivo
Akhtar, S., & Benter, I. F. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33494 · Cited by 464
Long-circulating pegylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery.
Calvo, P., Gouritin, B., Chacun, H., Desmaële, D., D'Angelo, J., Noel, J.-P., Georgin, D., Fattal, E., Andreux, J. P., & Couvreur, P. (2001) · Pharmaceutical Research · doi:10.1023/a:1010931127745 · Cited by 443
Self-citationHilbich, C., Kisters-Woike, B., Reed, J., Masters, C. L., & Beyreuther, K. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90835-8 · Cited by 413
Kakio, A., Nishimoto, S.-I., Yanagisawa, K., Kozutsumi, Y., & Matsuzaki, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100252200 · Cited by 406
Nanoparticles can cause DNA damage across a cellular barrier
Bhabra, G., Sood, A., Fisher, B., Cartwright, L., Saunders, M., Evans, W. H., Surprenant, A., Lopez-Castejon, G., Mann, S., Davis, S. A., et al. (2009) · Nature Nanotechnology · doi:10.1038/nnano.2009.313 · Cited by 381
β‐Amyloid efflux mediated by p‐glycoprotein
Lam, F. C., Liu, R., Lu, P., Shapiro, A. B., Renoir, J., Sharom, F. J., & Reiner, P. B. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00113.x · Cited by 380
Wilson, B., Samanta, M. K., Santhi, K., Kumar, K. P. S., Paramakrishnan, N., & Suresh, B. (2008) · Brain Research · doi:10.1016/j.brainres.2008.01.039 · Cited by 363
Clark, C. M., Xie, S., Chittams, J., Ewbank, D., Peskind, E., Galasko, D., Morris, J. C., McKeel, D. W., Farlow, M., Weitlauf, S. L., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.12.1696 · Cited by 357
Up-Regulated Production and Activation of the Complement System in Alzheimer's Disease Brain
Yasojima, K., Schwab, C., McGeer, E. G., & McGeer, P. L. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65340-0 · Cited by 327
Nanoparticle-Mediated Local and Remote Manipulation of Protein Aggregation
Kogan, M. J., Bastus, N. G., Amigo, R., Grillo-Bosch, D., Araya, E., Turiel, A., Labarta, A., Giralt, E., & Puntes, V. F. (2006) · Nano Letters · doi:10.1021/nl0516862 · Cited by 322
Choo-Smith, L.-P., Garzon-Rodriguez, W., Glabe, C. G., & Surewicz, W. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.37.22987 · Cited by 312
Yang, Z., Zhang, Y., Yang, Y., Sun, L., Han, D., Li, H., & Wang, C. (2010) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2009.11.007 · Cited by 311
Smith, A., Giunta, B., Bickford, P. C., Fountain, M., Tan, J., & Shytle, R. D. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.01.012 · Cited by 280
Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging
Wadghiri, Y. Z., Sigurdsson, E. M., Sadowski, M., Elliott, J. I., Li, Y., Scholtzova, H., Tang, C. Y., Aguinaldo, G., Pappolla, M., Duff, K., et al. (2003) · Magnetic Resonance in Medicine · doi:10.1002/mrm.10529 · Cited by 280
Aluminum modulates brain amyloidosis through oxidative stress in APP transgenic mice
Praticò, D., Uryu, K., Sung, S., Tang, S., Trojanowski, J. Q., & Lee, V. M. ‐. (2002) · The FASEB Journal · doi:10.1096/fj.02-0012fje · Cited by 278
WILSON, B., SAMANTA, M., SANTHI, K., KUMAR, K., PARAMAKRISHNAN, N., & SURESH, B. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.03.009 · Cited by 278
Hamad, I., Al-Hanbali, O., Hunter, A. C., Rutt, K. J., Andresen, T. L., & Moghimi, S. M. (2010) · ACS Nano · doi:10.1021/nn101990a · Cited by 276
Self-citationDual Effect of Amino Modified Polystyrene Nanoparticles on Amyloid β Protein Fibrillation
Cabaleiro-Lago, C., Quinlan-Pluck, F., Lynch, I., Dawson, K. A., & Linse, S. (2010) · ACS Chemical Neuroscience · doi:10.1021/cn900027u · Cited by 275
Batrakova, E. V., Li, S., Alakhov, V. Y., Miller, D. W., & Kabanov, A. V. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.043307 · Cited by 263
Efficient Inhibition of the Alzheimer's Disease β-Secretase by Membrane Targeting
Rajendran, L., Schneider, A., Schlechtingen, G., Weidlich, S., Ries, J., Braxmeier, T., Schwille, P., Schulz, J. B., Schroeder, C., Simons, M., et al. (2008) · Science · doi:10.1126/science.1156609 · Cited by 262
McLaurin, J., Franklin, T., Zhang, X., Deng, J., & Fraser, P. E. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00957.x · Cited by 258
Hamad, I., Hunter, A. C., Szebeni, J., & Moghimi, S. M. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.08.276 · Cited by 253
Self-citationNeely, A., Perry, C., Varisli, B., Singh, A. K., Arbneshi, T., Senapati, D., Kalluri, J. R., & Ray, P. C. (2009) · ACS Nano · doi:10.1021/nn900813b · Cited by 244
Joshi, S. A., Chavhan, S. S., & Sawant, K. K. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.07.007 · Cited by 235
Controlling Amyloid β-Peptide Fibril Formation with Protease-stable Ligands
Tjernberg, L. O., Lilliehöök, C., Callaway, D. J. E., Näslund, J., Hahne, S., Thyberg, J., Terenius, L., & Nordstedt, C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.19.12601 · Cited by 231
Ishrat, T., Hoda, M. N., Khan, M. B., Yousuf, S., Ahmad, M., Khan, M. M., Ahmad, A., & Islam, F. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.02.002 · Cited by 230
Curcumin-decorated nanoliposomes with very high affinity for amyloid-β1-42 peptide
Mourtas, S., Canovi, M., Zona, C., Aurilia, D., Niarakis, A., La Ferla, B., Salmona, M., Nicotra, F., Gobbi, M., & Antimisiaris, S. G. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.10.027 · Cited by 230
Lowe, T. L., Strzelec, A., Kiessling, L. L., & Murphy, R. M. (2001) · Biochemistry · doi:10.1021/bi002734u · Cited by 225
Polycation cytotoxicity: a delicate matter for nucleic acid therapy—focus on polyethylenimine
Parhamifar, L., Larsen, A. K., Hunter, A. C., Andresen, T. L., & Moghimi, S. M. (2010) · Soft Matter · doi:10.1039/c000190b · Cited by 213
Self-citationβ-Secretase (BACE) as a drug target for alzheimer’s disease
Vassar, R. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00157-6 · Cited by 210
King, M., Su, W., Chang, A., Zuckerman, A., & Pasternak, G. W. (2001) · Nature Neuroscience · doi:10.1038/85115 · Cited by 209
Moein Moghimi, S., Hamad, I., Andresen, T. L., Jørgensen, K., Szebeni, J., Moein Moghimi, S., Hamad, I., Andresen, T. L., Jørgensen, K., & Szebeni, J. (2006) · The FASEB Journal · doi:10.1096/fj.06-6186fje · Cited by 201
CUI, Z., LOCKMAN, P., ATWOOD, C., HSU, C., GUPTE, A., ALLEN, D., & MUMPER, R. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.07.009 · Cited by 200
Lipid-based nanoparticles with high binding affinity for amyloid-β1–42 peptide
Gobbi, M., Re, F., Canovi, M., Beeg, M., Gregori, M., Sesana, S., Sonnino, S., Brogioli, D., Musicanti, C., Gasco, P., et al. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.04.044 · Cited by 192
Iron: The Redox-active Center of Oxidative Stress in Alzheimer Disease
Castellani, R. J., Moreira, P. I., Liu, G., Dobson, J., Perry, G., Smith, M. A., & Zhu, X. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9360-7 · Cited by 180
Avdulov, N. A., Chochina, S. V., Igbavboa, U., Warden, C. S., Vassiliev, A. V., & Wood, W. G. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69041746.x · Cited by 180
Immunotherapy for Alzheimer's disease
Gélinas, D. S., Silva, K. D., Fenili, D., George‐Hyslop, P. S., & McLaurin, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404866101 · Cited by 180
Wang, J.-X., Sun, X., & Zhang, Z.-R. (2002) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00083-8 · Cited by 179
Size-dependent neurotoxicity of β-amyloid oligomers
Cizas, P., Budvytyte, R., Morkuniene, R., Moldovan, R., Broccio, M., Lösche, M., Niaura, G., Valincius, G., & Borutaite, V. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.02.001 · Cited by 179
The interaction between Alzheimer amyloid β(1–40) peptide and ganglioside GM1‐containing membranes
Choo-Smith, L.-P., & Surewicz, W. K. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01504-9 · Cited by 178
?-amyloid Ca2+-channel hypothesis for neuronal death in Alzheimer Disease
Arispe, N., Pollard, H. B., & Rojas, E. (1994) · Molecular and Cellular Biochemistry · doi:10.1007/bf00926750 · Cited by 169
Moghimi, S. M., Andersen, A. J., Hashemi, S. H., Lettiero, B., Ahmadvand, D., Hunter, A. C., Andresen, T. L., Hamad, I., & Szebeni, J. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.04.003 · Cited by 167
Self-citationBiochemical markers related to Alzheimer’s dementia in serum and cerebrospinal fluid
Teunissen, C. E., de Vente, J., Steinbusch, H. W. M., & De Bruijn, C. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00328-1 · Cited by 166
Advances in the treatment of neurodegenerative disorders employing nanotechnology
Modi, G., Pillay, V., & Choonara, Y. E. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05108.x · Cited by 164
Kim, H. R., Gil, S., Andrieux, K., Nicolas, V., Appel, M., Chacun, H., Desmaële, D., Taran, F., Georgin, D., & Couvreur, P. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6390-x · Cited by 163
Self-citationCharacterization of High-Affinity Binding between Gangliosides and Amyloid β-Protein
Ariga, T., Kobayashi, K., Hasegawa, A., Kiso, M., Ishida, H., & Miyatake, T. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2304 · Cited by 158
Picone, P., Bondì, M. L., Picone, P., Bondì, M. L., Montana, G., Bruno, A., Pitarresi, G. L., Giammona, G., & Carlo, M. D. (2009) · Free Radical Research · doi:10.1080/10715760903214454 · Cited by 156
Mulik, R. S., Mönkkönen, J., Juvonen, R. O., Mahadik, K. R., & Paradkar, A. R. (2010) · Molecular Pharmaceutics · doi:10.1021/mp900306x · Cited by 151
Nazem, A., & Mansoori, G. A. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-13210 · Cited by 150
Liu, G., Men, P., Kudo, W., Perry, G., & Smith, M. A. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.03.064 · Cited by 148
Amyloid-β detection with saccharide immobilized gold nanoparticle on carbon electrode
Chikae, M., Fukuda, T., Kerman, K., Idegami, K., Miura, Y., & Tamiya, E. (2008) · Bioelectrochemistry · doi:10.1016/j.bioelechem.2008.06.005 · Cited by 148
Superoxide Dismutase-Loaded PLGA Nanoparticles Protect Cultured Human Neurons Under Oxidative Stress
Reddy, M. K., Wu, L., Kou, W., Ghorpade, A., & Labhasetwar, V. D. (2008) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-008-8232-1 · Cited by 146
Self-citationBranched KLVFF Tetramers Strongly Potentiate Inhibition of β‐Amyloid Aggregation
Chafekar, S. M., Malda, H., Merkx, M., Meijer, E. W., Viertl, D., Lashuel, H. A., Baas, F., & Scheper, W. (2007) · ChemBioChem · doi:10.1002/cbic.200700338 · Cited by 145
Kabanov, A. V., Batrakova, E. V., & Alakhov, V. Y. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00211-6 · Cited by 143
Symonds, P., Murray, J. C., Hunter, A. C., Dębska, G., Szewczyk, A. M., & Moghimi, S. M. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.09.092 · Cited by 130
Self-citationKlajnert‐Maculewicz, B., Cortijo-Arellano, M., Bryszewska, M. J., & Cladera, J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.11.053 · Cited by 125
Hamad, I. M., Hunter, A. C., Rutt, K. J., Liu, Z., Dai, H., & Moghimi, S. M. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.05.020 · Cited by 123
Self-citationXu, G., Yong, K., Roy, I., Mahajan, S. D., Ding, H. Y., Schwartz, S. A., & Prasad, P. N. (2008) · Bioconjugate Chemistry · doi:10.1021/bc700477u · Cited by 120
Rocha, S., Thünemann, A. F., Pereira, M. D. C., Coelho, M. A. N., Möhwald, H., & Brezesinski, G. (2008) · Biophysical Chemistry · doi:10.1016/j.bpc.2008.06.010 · Cited by 113
Itagaki, S., Akiyama, H., Saito, H., & McGeer, P. L. (1994) · Brain Research · doi:10.1016/0006-8993(94)91640-3 · Cited by 112
Lockhart, I., Mitchell, S. A., & Kelly, S. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000255578 · Cited by 111
Amtul, Z., Wang, L., Westaway, D. A., & Rozmahel, R. F. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.05.031 · Cited by 110
Antiinflammatory Effects of Tetramethylpyrazine and Ferulic Acid.
OZAKI, Y. (1992) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.40.954 · Cited by 109
Agyare, E. K., Curran, G. L., Ramakrishnan, M., Yu, C. C., Poduslo, J. F., & Kandimalla, K. K. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9688-y · Cited by 104
Boridy, S., Takahashi, H., Akiyoshi, K., & Maysinger, D. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.06.010 · Cited by 103
A Condensation-Ordering Mechanism in Nanoparticle-Catalyzed Peptide Aggregation
Auer, S., Trovato, A., & Vendruscolo, M. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000458 · Cited by 102
Mulik, R. S., Mahadik, K. R., & Paradkar, A. R. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.03.009 · Cited by 101
Heli, H., Hajjizadeh, M., Jabbari, A., & Moosavi‐Movahedi, A. A. (2008) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2008.10.036 · Cited by 99
Skaat, H., & Margel, S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.06.110 · Cited by 92
Enhancement of transport of curcumin to brain in mice by poly(n-butylcyanoacrylate) nanoparticle
Sun, M. H., Gao, Y., Guo, C., Cao, F., Song, Z., Xi, Y., Yu, A., Li, A., & Zhai, G. (2010) · Journal of Nanoparticle Research · doi:10.1007/s11051-010-9907-4 · Cited by 92
Cherny, R. A., Barnham, K. J., Lynch, T., Volitakis, I., Li, Q.-X., McLean, C., Multhaup, G., Beyreuther, K. T., Tanzi, R. E., Masters, C. L., et al. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4285 · Cited by 88
Real-Time Imaging and Quantification of Amyloid-β Peptide Aggregates by Novel Quantum-Dot Nanoprobes
Tokuraku, K., Marquardt, M. M., & Ikezu, T. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008492 · Cited by 87
Charge-based binding of complement component C1q to the Alzheimer amyloid beta-peptide.
Webster, S. M., Bonnell, B. S., & Rogers, J. (1997) · Europe PMC (PubMed Central) · Cited by 86
Molecular Interactions of Dendrimers with Amyloid Peptides: pH Dependence
Klajnert‐Maculewicz, B., Cladera, J., & Bryszewska, M. J. (2006) · Biomacromolecules · doi:10.1021/bm060229s · Cited by 86
Patel, D. A., Henry, J. E., & Good, T. A. (2007) · Brain Research · doi:10.1016/j.brainres.2007.05.055 · Cited by 86
Pai, A., Rubinstein, I., & Önyüksel, H. (2006) · Peptides · doi:10.1016/j.peptides.2006.04.022 · Cited by 83
Williams, S. R., Lepene, B. S., Thatcher, C. D., & Long, T. E. (2008) · Biomacromolecules · doi:10.1021/bm801058j · Cited by 82
The possible role of complement activation in Alzheimer disease
McGeer, P. L., & McGeer, E. G. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02422-x · Cited by 81
Silva, G. A. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05361.x · Cited by 76
Kang, D.-Y., Lee, J., Oh, B., & Choi, J. (2008) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2008.08.018 · Cited by 72
Moretto, N., Bolchi, A., Rivetti, C., Imbimbo, B. P., Villetti, G., Pietrini, V., Polonelli, L., Signore, S. J. D., Smith, K. M., Ferrante, R. J., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609690200 · Cited by 70
Interaction between amyloid β‐protein aggregates and membranes
Kakio, A., Yano, Y., Takai, D., Kuroda, Y., Matsumoto, O., Kozutsumi, Y., & Matsuzaki, K. (2004) · Journal of Peptide Science · doi:10.1002/psc.570 · Cited by 68
Improved bioavailability of orally administered mifepristone from PLGA nanoparticles
HE, W., HORN, S., & HUSSAIN, M. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.10.025 · Cited by 67
Attenuation of β-amyloid induced toxicity by sialic acid-conjugated dendrimeric polymers
Patel, D. A., Henry, J. E., & Good, T. A. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2006.08.008 · Cited by 67
Hormonal treatment, mild cognitive impairment and Alzheimer's disease
Ryan, J. L., Scali, J., Carrière, I., Ritchie, K. A., & Ancelin, M. (2007) · International Psychogeriatrics · doi:10.1017/s1041610207006485 · Cited by 65
Multiple-Peptide Conjugates for Binding β-Amyloid Plaques of Alzheimer's Disease
Zhang, G., Leibowitz, M. J., Sinko, P. J., & Stein, S. (2002) · Bioconjugate Chemistry · doi:10.1021/bc025526i · Cited by 65
Skaat, H., Sorci, M., Belfort, G., & Margel, S. (2008) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.32232 · Cited by 64
Nanoscience enables ultrasensitive detection of Alzheimer's biomarker
Keating, C. D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500024102 · Cited by 64
Slowing the progression of cognitive decline in alzheimer’s disease using mifepristone
Belanoff, J. K., Jurik, J., Schatzberg, L. D., DeBattista, C., & Schatzberg, A. F. (2002) · Journal of Molecular Neuroscience · doi:10.1007/s12031-002-0033-3 · Cited by 63
Huang, H., Ou, H., Hsieh, S., & Chiang, L.-Y. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00470-7 · Cited by 61
Siegemund, T., Paulke, B. ‐., Schmiedel, H., Bordag, N., Hoffmann, A. H., Harkany, T., Tanila, H., Kacza, J., & Härtig, W. (2005) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2005.11.012 · Cited by 60
Brambilla, D., Verpillot, R., Taverna, M., Kimpe, L. D., Droumaguet, B. L., Nicolas, J., Canovi, M., Gobbi, M., Mantegazza, F., Salmona, M., et al. (2010) · Analytical Chemistry · doi:10.1021/ac102045x · Cited by 59
Self-citationChoi, J., Choi, H. J., Jung, D. C., Lee, J.-H., & Cheon, J. (2008) · Chemical Communications · doi:10.1039/b803294g · Cited by 55
Targeting the Brain – Surmounting or Bypassing the Blood–Brain Barrier
Potschka, H. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-00477-3_14 · Cited by 47
A gorge-spanning, high-affinity cholinesterase inhibitor to explore β-amyloid plaques
Elsinghorst, P. W., Härtig, W., Goldhammer, S., Grosche, J., & Gütschow, M. (2009) · Organic & Biomolecular Chemistry · doi:10.1039/b909612d · Cited by 47
GM1 Inhibits Amyloid β-Protein-Induced Cytokine Release
Ariga, T., & Yu, R. K. (1999) · Neurochemical Research · doi:10.1023/a:1022557920150 · Cited by 46
NEPHROPROTECTIVE AND HEPATOPROTECTIVE EFFECTS OF CURCUMINOIDS
Osawa, T. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-46401-5_18 · Cited by 46
Saraiva, A. M., Cardoso, I., Saraiva, M. J., Tauer, K., Pereira, M. D. C., Coelho, M. A. N., Möhwald, H., & Brezesinski, G. (2010) · Macromolecular Bioscience · doi:10.1002/mabi.200900448 · Cited by 43
Gold nanoparticles for selective and remote heating of β-amyloid protein aggregates
Bastús, N. G., Kogan, M. J., Amigo, R., Grillo‐Bosch, D., Araya, E., Turiel, A., Labarta, A., Giralt, E., & Puntes, V. (2006) · Materials Science and Engineering C · doi:10.1016/j.msec.2006.08.003 · Cited by 43
Treiber, C., Quadir, M., Voigt, P., Radowski, M. R., Xu, S., Munter, L. M., Bayer, T. A., Schaefer, M., Haag, R., & Multhaup, G. (2009) · Biochemistry · doi:10.1021/bi900290c · Cited by 36
Effects of rivastigmine on common symptomatology of Alzheimer’s disease (EXPLORE)
Gauthier, S. G., Juby, A. G., Dalziel, W. B., Réhel, B., Schecter, R., & on behalf of the EXPLORE investigators (2010) · Current Medical Research and Opinion · doi:10.1185/03007991003688888 · Cited by 35
Droumaguet, B. L., Souguir, H., Brambilla, D., Verpillot, R., Nicolas, J., Taverna, M., Couvreur, P., & Andrieux, K. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.01.015 · Cited by 31
Self-citationRozemüller, A. J. M., Bots, G. T. A. M., Roos, R. A. C., & Eikelenboom, P. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90087-n · Cited by 27
Härtig, W., Kacza, J., Paulke, B., Grosche, J., Bauer, U. U. I., Hoffmann, A., Elsinghorst, P. W., & Gütschow, M. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.07038.x · Cited by 27
C-1073 (Mifepristone) in the Adjunctive Treatment of Alzheimers Disease
DeBattista, C., & Belanoff, J. K. (2005) · Current Alzheimer Research · doi:10.2174/1567205053585954 · Cited by 25
Kolb (2001) · doi:10.1002/1521-3773(20010601)40:11<2004::aid-anie2004>3.0.co;2-5
Cited by
Nicolas, J., Mura, S., Brambilla, D., Mackiewicz, N., & Couvreur, P. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35265f · Cited by 1,270
Self-citationNanotheranostics for personalized medicine
Mura, S., & Couvreur, P. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.06.006 · Cited by 527
Self-citationNanotechnology and its Applications in Medicine
Nikalje, A. P. (2015) · Medicinal Chemistry · doi:10.4172/2161-0444.1000247 · Cited by 512
Albumin nanostructures as advanced drug delivery systems
Karimi, M., Bahrami, S., Ravari, S. B., Zangabad, P. S., Mirshekari, H., Bozorgomid, M., Shahreza, S., Sori, M., & Hamblin, M. R. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1193149 · Cited by 422
Point of care testing: The impact of nanotechnology
Syedmoradi, L., Daneshpour, M., Alvandipour, M., Gomez, F. A., Hajghassem, H., & Omidfar, K. (2017) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2016.08.084 · Cited by 367
Metadata
- Authors
- Brambilla, D., Le Droumaguet, B., Nicolas, J., Hashemi, S. H., Wu, L.-P., Moghimi, S. M., Couvreur, P., & Andrieux, K.
- Venue
- Nanomedicine: Nanotechnology, Biology and Medicine
- Publisher
- Elsevier BV
- Published
- 2011-10
- Volume
- 7
- Issue
- 5
- Pages
- 521-540
- ISSN
- 1549-9634 (ISSN-L)
- OpenAlex
- W2083452524
- Cited by
- 294
- References
- 147
- FWCI
- 15.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.